Get quick answers to your questions about the article from our AI researcher chatbot
{'id': 'https://openalex.org/W1964500934', 'doi': 'https://doi.org/10.1002/bdd.570', 'title': 'The effect of rifampicin and pyrazinamide on isoniazid pharmacokinetics in rats', 'display_name': 'The effect of rifampicin and pyrazinamide on isoniazid pharmacokinetics in rats', 'publication_year': 2007, 'publication_date': '2007-09-07', 'ids': {'openalex': 'https://openalex.org/W1964500934', 'doi': 'https://doi.org/10.1002/bdd.570', 'mag': '1964500934', 'pmid': 'https://pubmed.ncbi.nlm.nih.gov/17828712'}, 'language': 'en', 'primary_location': {'is_oa': False, 'landing_page_url': 'https://doi.org/10.1002/bdd.570', 'pdf_url': None, 'source': {'id': 'https://openalex.org/S57691945', 'display_name': 'Biopharmaceutics & Drug Disposition', 'issn_l': '0142-2782', 'issn': ['0142-2782', '1099-081X'], 'is_oa': False, 'is_in_doaj': False, 'is_core': True, 'host_organization': 'https://openalex.org/P4310320595', 'host_organization_name': 'Wiley', 'host_organization_lineage': ['https://openalex.org/P4310320595'], 'host_organization_lineage_names': ['Wiley'], 'type': 'journal'}, 'license': None, 'license_id': None, 'version': None, 'is_accepted': False, 'is_published': False}, 'type': 'article', 'type_crossref': 'journal-article', 'indexed_in': ['crossref', 'pubmed'], 'open_access': {'is_oa': False, 'oa_status': 'closed', 'oa_url': None, 'any_repository_has_fulltext': False}, 'authorships': [{'author_position': 'first', 'author': {'id': 'https://openalex.org/A5000136763', 'display_name': 'Helen Mariana Baldan', 'orcid': None}, 'institutions': [{'id': 'https://openalex.org/I879563668', 'display_name': 'Universidade Estadual Paulista (Unesp)', 'ror': 'https://ror.org/00987cb86', 'country_code': 'BR', 'type': 'education', 'lineage': ['https://openalex.org/I879563668']}], 'countries': ['BR'], 'is_corresponding': False, 'raw_author_name': 'Helen M. Baldan', 'raw_affiliation_strings': ['Departamento de Princípios Ativos Naturais e Toxicologia, Faculdade de Ciências Farmacêuticas, Universidade Estadual Paulista, Araraquara, SP, Brasil.'], 'affiliations': [{'raw_affiliation_string': 'Departamento de Princípios Ativos Naturais e Toxicologia, Faculdade de Ciências Farmacêuticas, Universidade Estadual Paulista, Araraquara, SP, Brasil.', 'institution_ids': ['https://openalex.org/I879563668']}]}, {'author_position': 'middle', 'author': {'id': 'https://openalex.org/A5017454008', 'display_name': 'Helene J. De Rosa', 'orcid': None}, 'institutions': [{'id': 'https://openalex.org/I879563668', 'display_name': 'Universidade Estadual Paulista (Unesp)', 'ror': 'https://ror.org/00987cb86', 'country_code': 'BR', 'type': 'education', 'lineage': ['https://openalex.org/I879563668']}], 'countries': ['BR'], 'is_corresponding': False, 'raw_author_name': 'Helene J. De Rosa', 'raw_affiliation_strings': ['Departamento de Princípios Ativos Naturais e Toxicologia, Faculdade de Ciências Farmacêuticas, Universidade Estadual Paulista, Araraquara, SP, Brasil.'], 'affiliations': [{'raw_affiliation_string': 'Departamento de Princípios Ativos Naturais e Toxicologia, Faculdade de Ciências Farmacêuticas, Universidade Estadual Paulista, Araraquara, SP, Brasil.', 'institution_ids': ['https://openalex.org/I879563668']}]}, {'author_position': 'middle', 'author': {'id': 'https://openalex.org/A5024537212', 'display_name': 'Iguatemy Lourenço Brunetti', 'orcid': 'https://orcid.org/0000-0003-4927-7599'}, 'institutions': [{'id': 'https://openalex.org/I879563668', 'display_name': 'Universidade Estadual Paulista (Unesp)', 'ror': 'https://ror.org/00987cb86', 'country_code': 'BR', 'type': 'education', 'lineage': ['https://openalex.org/I879563668']}], 'countries': ['BR'], 'is_corresponding': False, 'raw_author_name': 'Iguatemy L. Brunetti', 'raw_affiliation_strings': ['Departamento de Análises Clínicas, Faculdade de Ciências Farmacêuticas, Universidade Estadual Paulista, Araraquara, SP, Brasil'], 'affiliations': [{'raw_affiliation_string': 'Departamento de Análises Clínicas, Faculdade de Ciências Farmacêuticas, Universidade Estadual Paulista, Araraquara, SP, Brasil', 'institution_ids': ['https://openalex.org/I879563668']}]}, {'author_position': 'middle', 'author': {'id': 'https://openalex.org/A5075274024', 'display_name': 'Valdecir Farias Ximenes', 'orcid': 'https://orcid.org/0000-0003-2636-3080'}, 'institutions': [{'id': 'https://openalex.org/I879563668', 'display_name': 'Universidade Estadual Paulista (Unesp)', 'ror': 'https://ror.org/00987cb86', 'country_code': 'BR', 'type': 'education', 'lineage': ['https://openalex.org/I879563668']}], 'countries': ['BR'], 'is_corresponding': False, 'raw_author_name': 'Valdecir F. Ximenes', 'raw_affiliation_strings': ['Departamento de Química, Faculdade de Ciências, Universidade Estadual Paulista, Bauru, SP, Brasil'], 'affiliations': [{'raw_affiliation_string': 'Departamento de Química, Faculdade de Ciências, Universidade Estadual Paulista, Bauru, SP, Brasil', 'institution_ids': ['https://openalex.org/I879563668']}]}, {'author_position': 'last', 'author': {'id': 'https://openalex.org/A5023193081', 'display_name': 'Rosângela Gonçalves Peccinini', 'orcid': 'https://orcid.org/0000-0002-2692-8101'}, 'institutions': [{'id': 'https://openalex.org/I879563668', 'display_name': 'Universidade Estadual Paulista (Unesp)', 'ror': 'https://ror.org/00987cb86', 'country_code': 'BR', 'type': 'education', 'lineage': ['https://openalex.org/I879563668']}], 'countries': ['BR'], 'is_corresponding': False, 'raw_author_name': 'Rosângela G. P. Machado', 'raw_affiliation_strings': ['Departamento de Princípios Ativos Naturais e Toxicologia, Faculdade de Ciências Farmacêuticas, Universidade Estadual Paulista, Araraquara, SP, Brasil'], 'affiliations': [{'raw_affiliation_string': 'Departamento de Princípios Ativos Naturais e Toxicologia, Faculdade de Ciências Farmacêuticas, Universidade Estadual Paulista, Araraquara, SP, Brasil', 'institution_ids': ['https://openalex.org/I879563668']}]}], 'institution_assertions': [], 'countries_distinct_count': 1, 'institutions_distinct_count': 1, 'corresponding_author_ids': [], 'corresponding_institution_ids': [], 'apc_list': {'value': 3450, 'currency': 'USD', 'value_usd': 3450, 'provenance': 'doaj'}, 'apc_paid': None, 'fwci': 0.914, 'has_fulltext': True, 'fulltext_origin': 'ngrams', 'cited_by_count': 10, 'citation_normalized_percentile': {'value': 0.843331, 'is_in_top_1_percent': False, 'is_in_top_10_percent': False}, 'cited_by_percentile_year': {'min': 83, 'max': 84}, 'biblio': {'volume': '28', 'issue': '8', 'first_page': '409', 'last_page': '413'}, 'is_retracted': False, 'is_paratext': False, 'primary_topic': {'id': 'https://openalex.org/T11465', 'display_name': 'Mechanisms of Drug-Induced Hepatotoxicity', 'score': 0.9981, 'subfield': {'id': 'https://openalex.org/subfields/3004', 'display_name': 'Pharmacology'}, 'field': {'id': 'https://openalex.org/fields/30', 'display_name': 'Pharmacology, Toxicology and Pharmaceutics'}, 'domain': {'id': 'https://openalex.org/domains/1', 'display_name': 'Life Sciences'}}, 'topics': [{'id': 'https://openalex.org/T11465', 'display_name': 'Mechanisms of Drug-Induced Hepatotoxicity', 'score': 0.9981, 'subfield': {'id': 'https://openalex.org/subfields/3004', 'display_name': 'Pharmacology'}, 'field': {'id': 'https://openalex.org/fields/30', 'display_name': 'Pharmacology, Toxicology and Pharmaceutics'}, 'domain': {'id': 'https://openalex.org/domains/1', 'display_name': 'Life Sciences'}}, {'id': 'https://openalex.org/T11845', 'display_name': 'DNA Topoisomerases: Structure, Function, and Inhibition', 'score': 0.9964, 'subfield': {'id': 'https://openalex.org/subfields/1312', 'display_name': 'Molecular Biology'}, 'field': {'id': 'https://openalex.org/fields/13', 'display_name': 'Biochemistry, Genetics and Molecular Biology'}, 'domain': {'id': 'https://openalex.org/domains/1', 'display_name': 'Life Sciences'}}, {'id': 'https://openalex.org/T12318', 'display_name': 'Chemistry and Pharmacology of Quinazoline Compounds', 'score': 0.9963, 'subfield': {'id': 'https://openalex.org/subfields/1605', 'display_name': 'Organic Chemistry'}, 'field': {'id': 'https://openalex.org/fields/16', 'display_name': 'Chemistry'}, 'domain': {'id': 'https://openalex.org/domains/3', 'display_name': 'Physical Sciences'}}], 'keywords': [{'id': 'https://openalex.org/keywords/pyrazinamide', 'display_name': 'Pyrazinamide', 'score': 0.9148786}, {'id': 'https://openalex.org/keywords/idiosyncratic-reactions', 'display_name': 'Idiosyncratic Reactions', 'score': 0.40949}], 'concepts': [{'id': 'https://openalex.org/C2780459521', 'wikidata': 'https://www.wikidata.org/wiki/Q417571', 'display_name': 'Pyrazinamide', 'level': 4, 'score': 0.9148786}, {'id': 'https://openalex.org/C2778607973', 'wikidata': 'https://www.wikidata.org/wiki/Q422652', 'display_name': 'Rifampicin', 'level': 3, 'score': 0.8895407}, {'id': 'https://openalex.org/C112705442', 'wikidata': 'https://www.wikidata.org/wiki/Q323936', 'display_name': 'Pharmacokinetics', 'level': 2, 'score': 0.88348037}, {'id': 'https://openalex.org/C2776967927', 'wikidata': 'https://www.wikidata.org/wiki/Q423169', 'display_name': 'Isoniazid', 'level': 3, 'score': 0.80749744}, {'id': 'https://openalex.org/C98274493', 'wikidata': 'https://www.wikidata.org/wiki/Q128406', 'display_name': 'Pharmacology', 'level': 1, 'score': 0.79239}, {'id': 'https://openalex.org/C139254425', 'wikidata': 'https://www.wikidata.org/wiki/Q1332167', 'display_name': 'Volume of distribution', 'level': 3, 'score': 0.5816338}, {'id': 'https://openalex.org/C185592680', 'wikidata': 'https://www.wikidata.org/wiki/Q2329', 'display_name': 'Chemistry', 'level': 0, 'score': 0.5231858}, {'id': 'https://openalex.org/C97320921', 'wikidata': 'https://www.wikidata.org/wiki/Q718753', 'display_name': 'Drug interaction', 'level': 3, 'score': 0.43998843}, {'id': 'https://openalex.org/C110121322', 'wikidata': 'https://www.wikidata.org/wiki/Q865811', 'display_name': 'Distribution (mathematics)', 'level': 2, 'score': 0.4315519}, {'id': 'https://openalex.org/C76318530', 'wikidata': 'https://www.wikidata.org/wiki/Q16833590', 'display_name': 'Area under the curve', 'level': 2, 'score': 0.4267219}, {'id': 'https://openalex.org/C2781069245', 'wikidata': 'https://www.wikidata.org/wiki/Q12204', 'display_name': 'Tuberculosis', 'level': 2, 'score': 0.3751832}, {'id': 'https://openalex.org/C71924100', 'wikidata': 'https://www.wikidata.org/wiki/Q11190', 'display_name': 'Medicine', 'level': 0, 'score': 0.37211967}, {'id': 'https://openalex.org/C501593827', 'wikidata': 'https://www.wikidata.org/wiki/Q12187', 'display_name': 'Antibiotics', 'level': 2, 'score': 0.19549581}, {'id': 'https://openalex.org/C55493867', 'wikidata': 'https://www.wikidata.org/wiki/Q7094', 'display_name': 'Biochemistry', 'level': 1, 'score': 0.07313809}, {'id': 'https://openalex.org/C134306372', 'wikidata': 'https://www.wikidata.org/wiki/Q7754', 'display_name': 'Mathematical analysis', 'level': 1, 'score': 0.0}, {'id': 'https://openalex.org/C33923547', 'wikidata': 'https://www.wikidata.org/wiki/Q395', 'display_name': 'Mathematics', 'level': 0, 'score': 0.0}, {'id': 'https://openalex.org/C142724271', 'wikidata': 'https://www.wikidata.org/wiki/Q7208', 'display_name': 'Pathology', 'level': 1, 'score': 0.0}], 'mesh': [{'descriptor_ui': 'D000904', 'descriptor_name': 'Antibiotics, Antitubercular', 'qualifier_ui': 'Q000494', 'qualifier_name': 'pharmacology', 'is_major_topic': True}, {'descriptor_ui': 'D000995', 'descriptor_name': 'Antitubercular Agents', 'qualifier_ui': 'Q000493', 'qualifier_name': 'pharmacokinetics', 'is_major_topic': True}, {'descriptor_ui': 'D000995', 'descriptor_name': 'Antitubercular Agents', 'qualifier_ui': 'Q000494', 'qualifier_name': 'pharmacology', 'is_major_topic': True}, {'descriptor_ui': 'D007538', 'descriptor_name': 'Isoniazid', 'qualifier_ui': 'Q000493', 'qualifier_name': 'pharmacokinetics', 'is_major_topic': True}, {'descriptor_ui': 'D011718', 'descriptor_name': 'Pyrazinamide', 'qualifier_ui': 'Q000494', 'qualifier_name': 'pharmacology', 'is_major_topic': True}, {'descriptor_ui': 'D012293', 'descriptor_name': 'Rifampin', 'qualifier_ui': 'Q000494', 'qualifier_name': 'pharmacology', 'is_major_topic': True}, {'descriptor_ui': 'D000818', 'descriptor_name': 'Animals', 'qualifier_ui': '', 'qualifier_name': None, 'is_major_topic': False}, {'descriptor_ui': 'D000904', 'descriptor_name': 'Antibiotics, Antitubercular', 'qualifier_ui': '', 'qualifier_name': None, 'is_major_topic': False}, {'descriptor_ui': 'D000995', 'descriptor_name': 'Antitubercular Agents', 'qualifier_ui': '', 'qualifier_name': None, 'is_major_topic': False}, {'descriptor_ui': 'D019540', 'descriptor_name': 'Area Under Curve', 'qualifier_ui': '', 'qualifier_name': None, 'is_major_topic': False}, {'descriptor_ui': 'D002851', 'descriptor_name': 'Chromatography, High Pressure Liquid', 'qualifier_ui': '', 'qualifier_name': None, 'is_major_topic': False}, {'descriptor_ui': 'D004347', 'descriptor_name': 'Drug Interactions', 'qualifier_ui': '', 'qualifier_name': None, 'is_major_topic': False}, {'descriptor_ui': 'D006207', 'descriptor_name': 'Half-Life', 'qualifier_ui': '', 'qualifier_name': None, 'is_major_topic': False}, {'descriptor_ui': 'D007538', 'descriptor_name': 'Isoniazid', 'qualifier_ui': '', 'qualifier_name': None, 'is_major_topic': False}, {'descriptor_ui': 'D008297', 'descriptor_name': 'Male', 'qualifier_ui': '', 'qualifier_name': None, 'is_major_topic': False}, {'descriptor_ui': 'D011718', 'descriptor_name': 'Pyrazinamide', 'qualifier_ui': '', 'qualifier_name': None, 'is_major_topic': False}, {'descriptor_ui': 'D051381', 'descriptor_name': 'Rats', 'qualifier_ui': '', 'qualifier_name': None, 'is_major_topic': False}, {'descriptor_ui': 'D017208', 'descriptor_name': 'Rats, Wistar', 'qualifier_ui': '', 'qualifier_name': None, 'is_major_topic': False}, {'descriptor_ui': 'D012293', 'descriptor_name': 'Rifampin', 'qualifier_ui': '', 'qualifier_name': None, 'is_major_topic': False}], 'locations_count': 2, 'locations': [{'is_oa': False, 'landing_page_url': 'https://doi.org/10.1002/bdd.570', 'pdf_url': None, 'source': {'id': 'https://openalex.org/S57691945', 'display_name': 'Biopharmaceutics & Drug Disposition', 'issn_l': '0142-2782', 'issn': ['0142-2782', '1099-081X'], 'is_oa': False, 'is_in_doaj': False, 'is_core': True, 'host_organization': 'https://openalex.org/P4310320595', 'host_organization_name': 'Wiley', 'host_organization_lineage': ['https://openalex.org/P4310320595'], 'host_organization_lineage_names': ['Wiley'], 'type': 'journal'}, 'license': None, 'license_id': None, 'version': None, 'is_accepted': False, 'is_published': False}, {'is_oa': False, 'landing_page_url': 'https://pubmed.ncbi.nlm.nih.gov/17828712', 'pdf_url': None, 'source': {'id': 'https://openalex.org/S4306525036', 'display_name': 'PubMed', 'issn_l': None, 'issn': None, 'is_oa': False, 'is_in_doaj': False, 'is_core': False, 'host_organization': 'https://openalex.org/I1299303238', 'host_organization_name': 'National Institutes of Health', 'host_organization_lineage': ['https://openalex.org/I1299303238'], 'host_organization_lineage_names': ['National Institutes of Health'], 'type': 'repository'}, 'license': None, 'license_id': None, 'version': None, 'is_accepted': False, 'is_published': False}], 'best_oa_location': None, 'sustainable_development_goals': [{'score': 0.8, 'display_name': 'Good health and well-being', 'id': 'https://metadata.un.org/sdg/3'}], 'grants': [], 'datasets': [], 'versions': [], 'referenced_works_count': 17, 'referenced_works': ['https://openalex.org/W1561258300', 'https://openalex.org/W1563851197', 'https://openalex.org/W1983598515', 'https://openalex.org/W1991726497', 'https://openalex.org/W1995777252', 'https://openalex.org/W2001762433', 'https://openalex.org/W2005268756', 'https://openalex.org/W2006007325', 'https://openalex.org/W2039895358', 'https://openalex.org/W2040420065', 'https://openalex.org/W2064503376', 'https://openalex.org/W2064708864', 'https://openalex.org/W2067732089', 'https://openalex.org/W2139651041', 'https://openalex.org/W2144299665', 'https://openalex.org/W2407961555', 'https://openalex.org/W312065180'], 'related_works': ['https://openalex.org/W3158894753', 'https://openalex.org/W3104980608', 'https://openalex.org/W2353533277', 'https://openalex.org/W2351981588', 'https://openalex.org/W2186068470', 'https://openalex.org/W2160753277', 'https://openalex.org/W2154149749', 'https://openalex.org/W2019331484', 'https://openalex.org/W2002479294', 'https://openalex.org/W1906108293'], 'abstract_inverted_index': {'Abstract': [0], 'Tuberculosis': [1], 'chemotherapy': [2], 'involves': [3], 'combination': [4, 49, 154], 'of': [5, 25, 33, 37, 88, 105, 135], 'the': [6, 23, 30, 55, 86, 94, 123, 141, 150, 160, 169, 177, 186], 'drugs': [7, 179], 'isoniazid': [8], '(INH),': [9], 'rifampicin': [10], '(RMP)': [11], 'and': [12, 27, 111, 119, 146, 165, 188], 'pyrazinamide': [13], '(PYR)': [14], 'for': [15, 41], 'a': [16, 120, 147, 166], '6‐month': [17], 'period.': [18], 'The': [19, 153], 'present': [20], 'work': [21], 'investigated': [22], 'influence': [24], 'RMP': [26, 51, 136], 'PYR': [28, 89], 'on': [29], 'pharmacokinetic': [31, 174], 'parameters': [32], 'INH': [34, 45, 62, 65, 70, 75, 95], 'when': [35], 'groups': [36], 'rats': [38], 'were': [39], 'pre‐treated': [40], '21': [42], 'days': [43], 'with': [44, 50], 'alone': [46], 'or': [47], 'in': [48, 54, 93, 122, 140, 149, 159, 168, 185], 'and/or': [52], 'PYR,': [53], 'following': [56], 'amounts': [57], 'per': [58], 'kg': [59], 'body': [60], 'weight:': [61], '100': [63, 66, 68, 71, 76, 80], 'mg;': [64, 69, 74], 'mg+RMP': [67, 79], 'mg+PYR': [72, 77], '350': [73, 78], 'mg.': [81], 'It': [82], 'was': [83], 'found': [84], 'that': [85], 'co‐administration': [87], 'caused': [90, 137, 156], 'an': [91, 138, 157], 'increase': [92, 139, 158], 'distribution': [96], 'volume': [97], '(': [98, 107, 113, 131], 'V': [99], 'd': [100], '/': [101, 116, 144, 163], 'F': [102, 117, 145, 164], '),': [103, 118], 'half‐life': [104], 'elimination': [106], 't': [108], '1/2β': [109], ')': [110], 'clearance': [112], 'Cl': [114, 142, 161], 'T': [115, 143, 162], 'decrease': [121, 148, 167], 'area': [124], 'under': [125], 'curve': [126], '0': [127], 'to': [128, 183], '24': [129], 'h': [130], 'AUC': [132, 151, 170], ').': [133], 'Co‐administration': [134], '.': [152, 171], 'INH+PYR+RMP': [155], 'These': [172], 'significant': [173], 'interactions': [175], 'between': [176], 'tuberculostatic': [178], 'might': [180], 'be': [181], 'related': [182], 'differences': [184], 'therapeutic': [187], 'toxic': [189], 'effects.': [190], 'Copyright': [191], '©': [192], '2007': [193], 'John': [194], 'Wiley': [195], '&': [196], 'Sons,': [197], 'Ltd.': [198]}, 'cited_by_api_url': 'https://api.openalex.org/works?filter=cites:W1964500934', 'counts_by_year': [{'year': 2023, 'cited_by_count': 1}, {'year': 2022, 'cited_by_count': 1}, {'year': 2016, 'cited_by_count': 1}, {'year': 2015, 'cited_by_count': 1}, {'year': 2014, 'cited_by_count': 1}, {'year': 2013, 'cited_by_count': 1}, {'year': 2012, 'cited_by_count': 1}], 'updated_date': '2024-09-24T22:50:22.947617', 'created_date': '2016-06-24'}